The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation.

• Auteurs principaux: Nolan D Wood (Auteur), Danelle Smith (Auteur), Sally A Kinrade (Auteur), Mark T Sullivan (Auteur), Craig R Rayner (Auteur), David Wesche (Auteur), Kashyap Patel (Auteur), Karen Rowland-Yeo (Auteur)
• Format: Livre
• Publié: Public Library of Science (PLoS), 2024-08-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Moxidectin is approved by the US Food and Drug Administration (US FDA) for the treatment of onchocerciasis (river-blindness) due to Onchocerca volvulus in patients aged 12 years and older. In onchocerciasis-endemic areas, mass drug administration (MDA) programs with ivermectin, with or without vecto...